A review of 117 cases of unprovoked pulmonary embolism and further investigation in patients over 40.
作者信息
Angwin Chloe, Rochester Alana, Jawad Muhammad
机构信息
Surrey and Sussex Healthcare NHS Trust, Redhill, UK.
出版信息
Clin Med (Lond). 2020 Mar;20(Suppl 2):s64. doi: 10.7861/clinmed.20-2-s64.
Abstract
摘要
相似文献
1
A review of 117 cases of unprovoked pulmonary embolism and further investigation in patients over 40.
Clin Med (Lond). 2020 Mar;20(Suppl 2):s64. doi: 10.7861/clinmed.20-2-s64.
2
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
Am J Med. 2020 Aug;133(8):e406-e421. doi: 10.1016/j.amjmed.2020.03.040. Epub 2020 Apr 22.
3
Unprovoked Venous Thromboembolism: The Search for the Cause.
Med Clin North Am. 2023 Sep;107(5):861-882. doi: 10.1016/j.mcna.2023.05.006. Epub 2023 Jun 26.
4
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
Thromb Res. 2018 Feb;162:104-109. doi: 10.1016/j.thromres.2017.11.020. Epub 2017 Dec 8.
5
Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode.
Thromb Res. 2018 Feb;162:77-78. doi: 10.1016/j.thromres.2018.01.007. Epub 2018 Jan 4.
6
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry.
Thromb Res. 2023 Apr;224:17-20. doi: 10.1016/j.thromres.2023.02.006. Epub 2023 Feb 14.
7
Pulmonary embolism: update on management and controversies.
BMJ. 2020 Aug 5;370:m2177. doi: 10.1136/bmj.m2177.
8
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.
Eur Respir J. 2018 Jan 4;51(1). doi: 10.1183/13993003.01202-2017. Print 2018 Jan.
9
Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study.
Eur Respir J. 2022 Feb 3;59(2). doi: 10.1183/13993003.01801-2021. Print 2022 Feb.
10
[Risk of recurrence and duration of anticoagulant treatment after deep venous thromboembolism and pulmonary embolism].
Ugeskr Laeger. 2019 Feb 11;181(7).
本文引用的文献
1
Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.
Thromb Res. 2019 Apr;176:79-84. doi: 10.1016/j.thromres.2019.02.011. Epub 2019 Feb 13.
2
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD010837. doi: 10.1002/14651858.CD010837.pub4.
3
Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism.
Exp Clin Cardiol. 2013 Spring;18(2):129-38.
Zotero 插件